BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17549663)

  • 1. Investigation of tissue inhibitor of metalloproteinases 1 in plasma from colorectal cancer patients and blood donors by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Caspersen MB; Sørensen NM; Schrohl AS; Iversen P; Nielsen HJ; Brünner N
    Int J Biol Markers; 2007; 22(2):89-94. PubMed ID: 17549663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of the noncomplexed free fraction of tissue inhibitor of metalloproteinases 1 in plasma by immunoassay.
    Holten-Andersen MN; Christensen IJ; Nielsen HJ; Lilja H; Murphy G; Jensen V; Brünner N; Piironen T
    Clin Chem; 2002 Aug; 48(8):1305-13. PubMed ID: 12142388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer.
    Holten-Andersen MN; Murphy G; Nielsen HJ; Pedersen AN; Christensen IJ; Høyer-Hansen G; Brünner N; Stephens RW
    Br J Cancer; 1999 May; 80(3-4):495-503. PubMed ID: 10408859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the biological variation of plasma tissue inhibitor of metalloproteinases-1.
    Frederiksen CB; Lomholt AF; Lottenburger T; Davis GJ; Dowell BL; Blankenstein MA; Christensen IJ; Brunner N; Nielsen HJ
    Int J Biol Markers; 2008; 23(1):42-7. PubMed ID: 18409150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limitations in SELDI-TOF MS whole serum proteomic profiling with IMAC surface to specifically detect colorectal cancer.
    Wang Q; Shen J; Li ZF; Jie JZ; Wang WY; Wang J; Zhang ZT; Li ZX; Yan L; Gu J
    BMC Cancer; 2009 Aug; 9():287. PubMed ID: 19689818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.
    Oberg A; Höyhtyä M; Tavelin B; Stenling R; Lindmark G
    Anticancer Res; 2000; 20(2B):1085-91. PubMed ID: 10810401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitations in quantitation of the biomarker CCL18 in Gaucher disease blood samples by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    van Breemen MJ; Bleijlevens B; de Koster CG; Aerts JM
    Biochim Biophys Acta; 2006 Oct; 1764(10):1626-32. PubMed ID: 17010683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
    Liu XP; Shen J; Li ZF; Yan L; Gu J
    Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry.
    Engwegen JY; Helgason HH; Cats A; Harris N; Bonfrer JM; Schellens JH; Beijnen JH
    World J Gastroenterol; 2006 Mar; 12(10):1536-44. PubMed ID: 16570345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
    O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
    Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Behavior of MMP-2, MMP-7, MMP-9, and Their Inhibitors TIMP-1 and TIMP-2 in Adenoma-Colorectal Cancer Sequence.
    Barabás L; Hritz I; István G; Tulassay Z; Herszényi L
    Dig Dis; 2021; 39(3):217-224. PubMed ID: 32961536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SELDI-TOF serum proteomics and colorectal cancer: a current overview.
    Gemoll T; Roblick UJ; Auer G; Jörnvall H; Habermann JK
    Arch Physiol Biochem; 2010; 116(4-5):188-96. PubMed ID: 20615064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma or serum TIMP-1 is a predictor of survival outcomes in colorectal cancer: a meta-analysis.
    Lee JH; Choi JW; Kim YS
    J Gastrointestin Liver Dis; 2011 Sep; 20(3):287-91. PubMed ID: 21961097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer.
    Böckelman C; Beilmann-Lehtonen I; Kaprio T; Koskensalo S; Tervahartiala T; Mustonen H; Stenman UH; Sorsa T; Haglund C
    BMC Cancer; 2018 Jun; 18(1):679. PubMed ID: 29929486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperatively molecular staging with CM10 ProteinChip and SELDI-TOF-MS for colorectal cancer patients.
    Xu WH; Chen YD; Hu Y; Yu JK; Wu XG; Jiang TJ; Zheng S; Zhang SZ
    J Zhejiang Univ Sci B; 2006 Mar; 7(3):235-40. PubMed ID: 16502512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancer.
    Holten-Andersen MN; Stephens RW; Nielsen HJ; Murphy G; Christensen IJ; Stetler-Stevenson W; Brünner N
    Clin Cancer Res; 2000 Nov; 6(11):4292-9. PubMed ID: 11106246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of distinct serum proteomics for the biomarkers discovery in colorectal cancer.
    Xu W; Hu Y; Li J; He X; Fu Z; Pan T; Liu H; He H; Ge W; Yu J; Wei Q; Zheng S; Chen Y; Zhang S
    Discov Med; 2015 Oct; 20(110):239-53. PubMed ID: 26562477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative studies of tissue inhibitor of metalloproteinases-1 in plasma, serum and tumour tissue extracts from patients with primary colorectal cancer.
    Sørensen NM; Schrohl AS; Jensen V; Christensen IJ; Nielsen HJ; Brünner N
    Scand J Gastroenterol; 2008; 43(2):186-91. PubMed ID: 18224564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of tissue inhibitor of metalloproteinases 2 in plasma from healthy donors and cancer patients.
    Larsen MB; Stephens RW; Brünner N; Nielsen HJ; Engelholm LH; Christensen IJ; Stetler-Stevenson WG; Høyer-Hansen G
    Scand J Immunol; 2005 May; 61(5):449-60. PubMed ID: 15882437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of serum proteins as prognostic and predictive markers of colorectal cancer using surface enhanced laser desorption ionization-time of flight mass spectrometry.
    Helgason HH; Engwegen JY; Zapatka M; Vincent A; Cats A; Boot H; Beijnen JH; Schellens JH
    Oncol Rep; 2010 Jul; 24(1):57-64. PubMed ID: 20514444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.